Covaxin Maker Bharat Biotech’s Nasal Booster Dose Trials Get Approval
The Drug Controller Common of India nowadays gave the go-ahead for the Segment-III trials New Delhi: Vaccine producer Bharat Biotech
Read MoreThe Drug Controller Common of India nowadays gave the go-ahead for the Segment-III trials New Delhi: Vaccine producer Bharat Biotech
Read MoreBharat Biotech has carried out for Section I trial permission for a nasal Covid vaccine (Report) New Delhi: Hyderabad-based Bharat
Read More